Too often, people promote remedies for irritable bowel syndrome that have little to no scientific backing.

A massive, nearly 20-year study tracking over 650,000 Americans with irritable bowel syndrome is raising new questions about the long-term safety of common treatments. Researchers found that some ...

The biotech’s CEO, Dr James McIlroy, says EBX-102-02 could address significant treatment gaps in IBS, which impacts up to 10% ...

A massive long-term study tracking more than 650,000 Americans with irritable bowel syndrome is raising new concerns about the safety of some commonly used treatments.

Irritable bowel syndrome (IBS) is a chronic condition that can cause a number of unpleasant digestive symptoms, most notably constipation or diarrhea with abdominal pain. "Gas, cramping and food ...

Funds will support one of the largest interventional clinical trials of a full-spectrum microbiome product, and the largest ever to be conducted in IBSDosing of first patient of the Phase 2b ‘RISE’ ...

Real-world clinical experience with the novel IBS-specific guided diagnostic therapy to be presented at the world’s largest GI medical conference, May 2–5, 2026, in ChicagoIRVINE, Calif., April 29, ...

Living with IBS can feel like a constant guessing game, but the low FODMAP diet offers a structured way to identify and manage trigger foods. This three-phase approach—elimination, reintroduction, and ...

Often dismissed as a minor issue, bloating can be your body’s early warning signal of hidden ailments. Paying attention to ...

Confused between IBS, acidity, and gas? Here's a simple guide to understanding the differences, symptoms, and causes so you ...